These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2886588)

  • 1. Dose-related inhibition of the drug-metabolizing enzymes of rat liver by the pyrrolizidine alkaloid, monocrotaline.
    Dalvi RR
    J Pharm Pharmacol; 1987 May; 39(5):386-8. PubMed ID: 2886588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors.
    Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M
    Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picroliv protects against monocrotaline-induced hepatic damage in rats.
    Dwivedi Y; Rastogi R; Sharma SK; Mehrotra R; Garg NK; Dhawan BN
    Pharmacol Res; 1991 May; 23(4):399-407. PubMed ID: 1908581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of piperine administered intragastrically and intraperitoneally on the liver and liver mixed-function oxidases in rats.
    Dalvi RR; Dalvi PS
    Drug Metabol Drug Interact; 1991; 9(1):23-30. PubMed ID: 1893751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutathione in the reduction of captan-induced in vivo inhibition of monooxygenases and liver toxicity in the rat.
    Dalvi RR
    J Environ Sci Health B; 1988 Apr; 23(2):171-8. PubMed ID: 3385136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanguinarine: its potential as a liver toxic alkaloid present in the seeds of Argemone mexicana.
    Dalvi RR
    Experientia; 1985 Jan; 41(1):77-8. PubMed ID: 3967743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of monocrotaline-induced hepatic genotoxicity in rats.
    Petry TW; Sipes IG
    Carcinogenesis; 1987 Mar; 8(3):415-9. PubMed ID: 3102099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
    Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
    Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline.
    Petry TW; Bowden GT; Huxtable RJ; Sipes IG
    Cancer Res; 1984 Apr; 44(4):1505-9. PubMed ID: 6423276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
    Smith BJ; Hu JK; Schwecke WP
    Drug Chem Toxicol; 1998 Aug; 21(3):291-303. PubMed ID: 9706462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional state of the hepatocyte cytoplasmic network in heliotrine injury of the rat liver].
    Khakimov ZZ
    Vopr Med Khim; 1985; 31(4):80-2. PubMed ID: 4049792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphology.
    Graichen ME; Neptun DA; Dent JG; Popp JA; Leonard TB
    Fundam Appl Toxicol; 1985 Feb; 5(1):165-74. PubMed ID: 2859228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ; Hubbard AK; Huxtable RJ
    J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure.
    Culvenor CC; Edgar JA; Jago MV; Qutteridge A; Peterson JE; Smith LW
    Chem Biol Interact; 1976 Mar; 12(3-4):299-324. PubMed ID: 1253333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
    Wang YP; Yan J; Beger RD; Fu PP; Chou MW
    Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.